Curing Depression in One Dose?
1 extracted signal · 0 resolved · 1 still active
Lou BaseneseIndependent analyst profile- Source published
- 05 Sept 2026, 16:30 UTC
- Recorded by Tahlil Plus
- 05 Sept 2026, 17:21 UTC
AI-generated source summary
The speaker discusses a company, CMPS, which was trading at approximately $20 in April. The company has been progressing through three Phase III trials this year, with two of them yielding positive results. This has led to a significant increase in the stock price, up over 130%. The speaker believes the stock can double from its current price, suggesting a bullish outlook. The analysis implies a target of around $30, with a failure bound set below $8, indicating a strong conviction in the upward trajectory.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Lou Basenese
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.